Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.45 |
| ▸ | LDHB | P07195 | 1/20 | 0.45 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | CSF1R | P07333 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17495564 | 1.00 | KDM4E (0.52) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL29952713 | 0.88 | KDM4E (0.59) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL19206900 | 0.86 | TDP1 (0.47) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL19206902 | 0.86 | KDM4E (0.41) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL19206901 | 0.86 | TDP1 (0.47) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL23828689 | 0.84 | ALDH1A1 (0.48) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL18911025 | 0.83 | ALDH1A1 (0.44) | KDM4ETDP1POLBLMNAALDH1A1 | |
| Sumiki'S Acid SCHEMBL28619852 | 0.83 | TDP1 (0.69) | KDM4ETDP1POLBALDH1A1TSHR | |
| Aes-103 SCHEMBL28643076 | 0.82 | ALDH1A1 (0.73) | KDM4ETDP1POLBLMNAALDH1A1 | |
| SCHEMBL9073749 | 0.80 | TDP1 (0.45) | TDP1POLBALDH1A1HPGDHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2100 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371411-B2 | Water and thermal treatment of purified 2,5-furandicarboxylic acid | Furanix Technologies B, V. (NL) | 2025-07-29 | — | — | US | claimed |
| US-12365660-B2 | Organic acid and thermal treatment of purified 2,5-furandicarboxylic acid | FURANIX TECHNOLOGIES B.V. (NL) | 2025-07-22 | — | — | US | claimed |
| US-20250223272-A1 | COOLING PROCESSES TO PRODUCE ACFC WITH INCREASED CRYSTAL SIZE WITH PURGE | EASTMAN CHEMICAL COMPANY (US) | 2025-07-10 | — | — | US | claimed |
| EP-4574988-A1 | PROCESS FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID | Annikki GmbH (AT) | 2025-06-25 | — | — | EP | claimed |
| EP-4574987-A1 | PROCESS FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID | Annikki GmbH (AT) | 2025-06-25 | — | — | EP | claimed |
| US-12336973-B2 | Cancer therapeutic compositions and methods targeting DNAse1L3 | PROVIDENCE HEALTH & SERVICES—OREGON (US) | 2025-06-24 | — | — | US | claimed |
| US-20250197367-A1 | PROCESS FOR THE OXIDATION OF HYDROXYMETHYLFURFURAL | Südzucker AG (DE) | 2025-06-19 | — | — | US | claimed |
| CN-117088833-B | Method for preparing formyl-2-furancarboxylic acid from 5-hydroxymethylfurfural | 烟台大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120041518-A | Method for synthesizing furan acid compound by catalyzing 5-hydroxymethylfurfural through chemical enzyme cascade | 南京工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119985789-A | Method for simultaneously measuring 5-hydroxymethylfurfural and oxidation products thereof | 中国科学院宁波材料技术与工程研究所 | 2025-05-13 | — | — | CN | claimed |
| CN-102405207-A | Spray process for selective oxidation | UNIV KANSAS | 2012-04-04 | — | — | CN | claimed |
| EP-2411357-A2 | SPRAY PROCESS FOR SELECTIVE OXIDATION | University Of Kansas (US) | 2012-02-01 | — | — | EP | claimed |
| WO-2010111288-A2 | SPRAY PROCESS FOR SELECTIVE OXIDATION | UNIVERSITY OF KANSAS (US) | 2010-09-30 | — | — | WO | claimed |
| US-7429603-B2 | Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2008-09-30 | — | — | US | claimed |
| US-7411078-B2 | Method for producing furan-2,5-dicarboxylic acid | CANON KABUSHIKI KAISHA (JP) | 2008-08-12 | — | — | US | claimed |
| US-20070232815-A1 | METHOD FOR PRODUCING FURAN-2,5-DICARBOXYLIC ACID | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | claimed |
| EP-1631560-A2 | C-FMS KINASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2006-03-08 | — | — | EP | claimed |
| US-20050004112-A1 | C-fms kinase inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | claimed |
| WO-2004096795-A2 | C-FMS KINASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2004-11-11 | — | — | WO | claimed |
| EP-0045150-A1 | Antibacterial compounds, processes for their preparation and composititions containing them | BEECHAM GROUP PLC (GB) | 1982-02-03 | — | — | EP | claimed |